Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1992;70:1128-1136

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clowes, A. W.
Right arrow Articles by Kenagy, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clowes, A. W.
Right arrow Articles by Kenagy, R.

Circulation Research, Vol 70, 1128-1136, Copyright © 1992 by American Heart Association


ARTICLES

Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery

AW Clowes, MM Clowes, TR Kirkman, CL Jackson, YP Au and R Kenagy
Department of Surgery, University of Washington, Seattle.

Smooth muscle cells (SMCs) in balloon-injured rat carotid artery express tissue-type plasminogen activator (t-PA) at a time when they are migrating from the media to the intima. Since heparin inhibits SMC migration and intimal thickening, we have examined the possibility that heparin might also inhibit t-PA expression. Heparin (nonanticoagulant fraction; molecular weight, approximately 6,000) was administered by continuous intravenous infusion (1.0 mg/kg per hour) to Sprague-Dawley rats subjected to balloon injury of the left common carotid artery. At various times up to 14 days after injury, plasminogen activator expression was analyzed by zymography, plasmin generation, enzyme- linked immunosorbent assay, Northern blotting, and in situ hybridization. This dose of heparin inhibited SMC accumulation at 14 days by 60%. Both urokinase plasminogen activator (u-PA) and t-PA activity increased in injured arteries and reached a maximum at 7 days. Heparin treatment decreased t-PA, but not u-PA, activity. Total t-PA protein was decreased by treatment with heparin but not chondroitin sulfate, and the decrease in t-PA protein was associated with decreased t-PA mRNA in the media. These results in the injured rat carotid artery agree with our earlier observations that heparin inhibits t-PA gene expression in cultured baboon aortic SMCs. They also provide support for the hypothesis that heparin interferes with the expression of certain proteases required for SMC migration and proliferation.


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
S. M. Smorenburg and C. J. F. Van Noorden
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Hasenstab, H. Lea, and A. W. Clowes
Local Plasminogen Activator Inhibitor Type 1 Overexpression in Rat Carotid Artery Enhances Thrombosis and Endothelial Regeneration While Inhibiting Intimal Thickening
Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C Newby and A. B Zaltsman
Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
Cardiovasc Res, February 1, 1999; 41(2): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. K. Belknap, M. C. M. Weiser-Evans, S. S. Grieshaber, R. A. Majack, and K. R. Stenmark
Relationship between Perlecan and Tropoelastin Gene Expression and Cell Replication in the Developing Rat Pulmonary Vasculature
Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 24 - 34.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Allaire, D. Hasenstab, R. D. Kenagy, B. Starcher, M. M. Clowes, and A. W. Clowes
Prevention of Aneurysm Development and Rupture by Local Overexpression of Plasminogen Activator Inhibitor-1
Circulation, July 21, 1998; 98(3): 249 - 255.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Sindermann and K. L. March
Heparin Responsiveness In Vitro as a Prognostic Tool for Vascular Graft Stenosis : A Tale of Two Cell Types?
Circulation, June 30, 1998; 97(25): 2486 - 2490.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Dilley and M. I. Nataatmadja
Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats
Cardiovasc Res, April 1, 1998; 38(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes
Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9
Circulation, November 18, 1997; 96(10): 3555 - 3560.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-M. Herbert, I. Lamarche, and P. Carmeliet
Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells
J. Biol. Chem., September 19, 1997; 272(38): 23585 - 23591.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Ellis and S. A. Whawell
Vascular Smooth Muscle Cells Potentiate Plasmin Generation by Both Urokinase and Tissue Plasminogen Activator-Dependent Mechanisms: Evidence for a Specific Tissue-Type Plasminogen Activator Receptor on These Cells
Blood, September 15, 1997; 90(6): 2312 - 2322.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Hasenstab, R. Forough, and A. W. Clowes
Plasminogen Activator Inhibitor Type 1 and Tissue Inhibitor of Metalloproteinases-2 Increase After Arterial Injury in Rats
Circ. Res., April 19, 1997; 80(4): 490 - 496.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. Allaire and A. W. Clowes
Endothelial Cell Injury in Cardiovascular Surgery: The Intimal Hyperplastic Response
Ann. Thorac. Surg., February 1, 1997; 63(2): 582 - 591.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R.D. Kenagy, S. Vergel, E. Mattsson, M. Bendeck, M.A. Reidy, and A.W. Clowes
The Role of Plasminogen, Plasminogen Activators, and Matrix Metalloproteinases in Primate Arterial Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1373 - 1382.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
M. Janiszewski, F. R. M. Laurindo, C. A. Pasqualucci, P. L. da Luz, and F. Pileggi
Effects of a Single Heparin Bolus on Neointimal Growth After Arterial Injury in Intact Rabbits
Angiology, June 1, 1996; 47(6): 549 - 556.
[Abstract] [PDF]


Home page
Circ. Res.Home page
W. Wang, H. J. Chen, K. N. Giedd, A. Schwartz, P. J. Cannon, and L. E. Rabbani
T-Cell Lymphokines, Interleukin-4 and Gamma Interferon, Modulate the Induction of Vascular Smooth Muscle Cell Tissue Plasminogen Activator and Migration by Serum and Platelet-Derived Growth Factor
Circ. Res., December 1, 1995; 77(6): 1095 - 1106.
[Abstract] [Full Text]


Home page
CirculationHome page
R. L. Geary, N. Koyama, T. W. Wang, S. Vergel, and A. W. Clowes
Failure of Heparin to Inhibit Intimal Hyperplasia in Injured Baboon Arteries : The Role of Heparin-Sensitive and -Insensitive Pathways in the Stimulation of Smooth Muscle Cell Migration and Proliferation
Circulation, June 15, 1995; 91(12): 2972 - 2981.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. C. Woods, C. R. Blystone, J. Yoo, and E. R. Edelman
Activation of EphB2 and Its Ligands Promotes Vascular Smooth Muscle Cell Proliferation
J. Biol. Chem., January 11, 2002; 277(3): 1924 - 1927.
[Abstract] [Full Text] [PDF]